Nomura Asset Management Co. Ltd. Buys 184,113 Shares of Astera Labs, Inc. $ALAB

Nomura Asset Management Co. Ltd. raised its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 63.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 473,179 shares of the company’s stock after buying an additional 184,113 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Astera Labs were worth $78,718,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ALAB. Royal Bank of Canada grew its position in shares of Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after buying an additional 95,409 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC grew its position in shares of Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the last quarter. First Trust Advisors LP grew its position in shares of Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. grew its position in shares of Astera Labs by 54.9% in the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after buying an additional 1,977 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ALAB shares. Stifel Nicolaus upped their target price on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Needham & Company LLC upped their target price on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Roth Mkm restated a “buy” rating and set a $275.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday. Finally, Susquehanna upped their target price on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Insider Buying and Selling

In related news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 2,316,257 shares of company stock valued at $474,860,636. 12.50% of the stock is owned by company insiders.

Astera Labs Stock Performance

ALAB stock opened at $343.05 on Friday. The stock’s 50 day simple moving average is $190.82 and its 200 day simple moving average is $165.12. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $354.53. The company has a market cap of $58.80 billion, a P/E ratio of 231.79, a price-to-earnings-growth ratio of 4.54 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period in the prior year, the business earned $0.33 EPS. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.